SERVICES

Tag Archives | Optimal Therapeutics

New Jersey Based Optimal Therapeutics Announces the Signing of Licensing Agreement for the Trademarked Ingredient Nextrutine(R) in Their Phosoplex Joint Formulation

CEDAR GROVE, NJ /Send2Press Newswire/ — New Jersey based Optimal Therapeutics announces the signings of licensing agreements for trademarked ingredients in their Phosoplex Joint Formulation. BioCell Collagen II from BioCell Technology LLC and Nextrutine(R) from Next Pharmaceutical are exciting ingredient additions to an already potent joint health formula.

Continue Reading

Part of the Neotrope® News Network, USA. Neotrope.net